The Risk of Growth in Patients With Non-malignant Brain Tumor: SeOuL cOhort of Brain Tumor MONitoring (SOLOMON) Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The registry of this study was subjected to patients who were radiologically diagnosed with a non-malignant brain tumor at Seoul National University Hospital since 2001, and who have had magnetic resonance (MR) re-examination after first MR exam or will be re-examined because it was determined that immediate treatment would not be needed at the first visit to the hospital. In all MRs taken by patients, the date of imaging and the volume of the tumor are measured, and we aim to establish a natural growth history for non-malignant brain tumors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with radiologically diagnosed brain neoplasm of CNS WHO grade 2 or less since 1998

• Asymptomatic at first visit to the hospital

• Patients who, based on the up-to-date knowledge, did not necessarily require immediate treatment at the first hospital visit

• Patients who have had two or more MRs at least 3 months apart

• No previous radiotherapy or radiosurgery for the brain lesion

• 18 years old or more

• Patients with newly diagnosed brain neoplasm of CNS WHO grade 2 or less

• Asymptomatic at first visit to the hospital

• Patients who, based on the up-to-date knowledge, did not necessarily require immediate treatment at the first hospital visit and who are going to take follow-up MR exams

• No previous radiotherapy or radiosurgery for the brain lesion

• 18 years old or more

• Patients who agree to participate by written consent

Locations
Other Locations
Republic of Korea
Seoul National University Hospital
RECRUITING
Seoul
Contact Information
Primary
Chul-Kee Park, MD PhD
nsckpark@snu.ac.kr
+82220720347
Time Frame
Start Date: 2001-01-01
Estimated Completion Date: 2035-12-31
Participants
Target number of participants: 3000
Treatments
Retrospective cohort
The registry of this study was subjected to patients who were radiologically diagnosed with a non-malignant brain tumor at Seoul National University Hospital since 1998, and who have had MR re-examination after first MR exam because it was determined that immediate treatment would not be needed at the first visit to the hospital. Non-malignant brain tumors are defined as radiologically diagnosed primary intracranial neoplasms of CNS WHO grade 2 or lower and include meningioma, schwannoma, pituitary adenoma, and glioma suspected to be non-malignant. It is practically impossible to obtain informed consent from patients of this retrospective cohort, and consent was waived by the Institutional Review Board. Target population of this retrospective cohort is 1,500 tumors.
Prospective cohort
The registry of this study was subjected to patients who were radiologically diagnosed with a non-malignant brain tumor at Seoul National University Hospital since February 2022, and who have had MR re-examination after first MR exam or will be re-examined because it was determined that immediate treatment would not be needed at the first visit to the hospital. Non-malignant brain tumors are defined as radiologically diagnosed primary intracranial neoplasms of CNS WHO grade 2 or lower and include meningioma, schwannoma, pituitary adenoma, and glioma suspected to be non-malignant. The cohort will consists of patients who agree to participate with written consent. Target population of this prospective cohort is 1,500 tumors.
Sponsors
Leads: Seoul National University Hospital

This content was sourced from clinicaltrials.gov